Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franco Cavalli

Showing results (71-80 of 151) with videos related to

Pageof 16
Sort By:
Leukemia & Lymphoma|April 15, 2003
HIV-testing and newly-diagnosed malignant lymphomas. The SAKK 96/90 registration studyGiannicola D'Addario, Alexander Dieterle, Joachim Torhorst, et al.
Leukemia & Lymphoma|June 19, 2004
Pathobiology of primary mediastinal B-cell lymphomaStefano A Pileri, Pier L Zinzani, Gianluca Gaidano, et al.
Hematological Oncology|October 26, 2020
A phase II trial of bendamustine in combination with ofatumumab in patients with relapsed or refractory marginal zone B-cell lymphomasBarbara Vannata, Anna Vanazzi, Mara Negri, et al.
Leukemia & Lymphoma|February 28, 2007
Low prevalence of Chlamydia psittaci in ocular adnexal lymphomas from Cuban patientsElías Gracia, Patrizia Froesch, Luca Mazzucchelli, et al.
Leukemia & Lymphoma|August 19, 2021
A phase I trial of inotuzumab ozogamicin in combination with temsirolimus in patients with relapsed or refractory CD22-positive B-cell non-Hodgkin lymphomasMaria C Pirosa, Lu Zhang, Felicitas Hitz, et al.
Leukemia & Lymphoma|January 24, 2013
Risk factors of central nervous system relapse in mantle cell lymphomaAnnarita Conconi, Silvia Franceschetti, Chiara Lobetti-Bodoni, et al.
Cancer Gene Therapy|March 16, 2002
Immunotherapy of metastatic melanoma by intratumoral injections of Vero cells producing human IL-2: phase II randomized study comparing two dose levelsChristoph Rochlitz, Brigitte Dreno, Peter Jantscheff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2007
Definition, diagnosis, and management of intravascular large B-cell lymphoma: proposals and perspectives from an international consensus meetingMaurilio Ponzoni, Andrés J M Ferreri, Elías Campo, et al.
Haematologica|November 2, 2020
Early progression of disease predicts shorter survival in MALT lymphoma patients receiving systemic treatmentAnnarita Conconi, Catherine Thieblemont, Luciano Cascione, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2003
Summary statement on primary central nervous system lymphomas from the Eighth International Conference on Malignant Lymphoma, Lugano, Switzerland, June 12 to 15, 2002Andrés J M Ferreri, Lauren E Abrey, Jean-Yves Blay, et al.
Pageof 16

Showing results (71-80 of 151) with videos related to

Sort By:
Pageof 16
Leukemia & Lymphoma|April 15, 2003
HIV-testing and newly-diagnosed malignant lymphomas. The SAKK 96/90 registration studyGiannicola D'Addario, Alexander Dieterle, Joachim Torhorst, et al.
Leukemia & Lymphoma|June 19, 2004
Pathobiology of primary mediastinal B-cell lymphomaStefano A Pileri, Pier L Zinzani, Gianluca Gaidano, et al.
Hematological Oncology|October 26, 2020
A phase II trial of bendamustine in combination with ofatumumab in patients with relapsed or refractory marginal zone B-cell lymphomasBarbara Vannata, Anna Vanazzi, Mara Negri, et al.
Leukemia & Lymphoma|February 28, 2007
Low prevalence of Chlamydia psittaci in ocular adnexal lymphomas from Cuban patientsElías Gracia, Patrizia Froesch, Luca Mazzucchelli, et al.
Leukemia & Lymphoma|August 19, 2021
A phase I trial of inotuzumab ozogamicin in combination with temsirolimus in patients with relapsed or refractory CD22-positive B-cell non-Hodgkin lymphomasMaria C Pirosa, Lu Zhang, Felicitas Hitz, et al.
Leukemia & Lymphoma|January 24, 2013
Risk factors of central nervous system relapse in mantle cell lymphomaAnnarita Conconi, Silvia Franceschetti, Chiara Lobetti-Bodoni, et al.
Cancer Gene Therapy|March 16, 2002
Immunotherapy of metastatic melanoma by intratumoral injections of Vero cells producing human IL-2: phase II randomized study comparing two dose levelsChristoph Rochlitz, Brigitte Dreno, Peter Jantscheff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2007
Definition, diagnosis, and management of intravascular large B-cell lymphoma: proposals and perspectives from an international consensus meetingMaurilio Ponzoni, Andrés J M Ferreri, Elías Campo, et al.
Haematologica|November 2, 2020
Early progression of disease predicts shorter survival in MALT lymphoma patients receiving systemic treatmentAnnarita Conconi, Catherine Thieblemont, Luciano Cascione, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2003
Summary statement on primary central nervous system lymphomas from the Eighth International Conference on Malignant Lymphoma, Lugano, Switzerland, June 12 to 15, 2002Andrés J M Ferreri, Lauren E Abrey, Jean-Yves Blay, et al.
Pageof 16